Determine the extent to which estimates of sample and effect size in stroke rehabilitation trials can be affected by simple summation of ordinal Upper Extremity Fugl-Meyer (UEFM) items compared to a Rasch-rescaled UEFM.
To report the cognitive features of severe COVID-19 patients entering in the post-acute phase, to understand whether COVID-19 acute respiratory distress syndrome itself could result in long-term cognitive deficits and whether neuropsychological treatment after the acute stage might represent a specific rehabilitation need.
Examine the association of patient and direct-care staff beliefs about patients’ capability to increase independence with activities of daily living (ADLs) and the probability of successful discharge to the community following a skilled nursing facility (SNF) stay.
Multiple sclerosis (MS) is caused by an overactive immune system, which results in scarring of the coating that surrounds the nerves (myelin) in the brain, eyes, and spinal cord. An estimated 1 million individuals in the United States and 2,500,000 worldwide live with MS. Many individuals with MS will at some point experience vision problems. These vision problems can be managed by medical and rehabilitation treatment. This Information/Education Page was developed to help individuals living with MS, their family, and caregivers to better understand vision problems that often appear during the course of the disease, as well as rehabilitation options to treat vision problems.
To provide prevalence estimates for problems in functioning of community-dwelling persons with spinal cord injury (SCI) and to examine associations between various areas of functioning with the purpose of supporting countries in identifying targets for interventions.